Catalyst Wire Dossier Catalyst Wire Dossier

OPC-1085EL ophthalmic solution

OPC-1085EL · Otsuka Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for OPC-1085EL ophthalmic solution, covering 2015-04-02 to 2015-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension [Phase 3]

See pricing